SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227712
Filing Date
2023-09-01
Accepted
2023-09-01 16:45:55
Documents
15
Period of Report
2023-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d482665d8k.htm   iXBRL 8-K 31835
2 EX-5.1 d482665dex51.htm EX-5.1 11247
3 EX-10.1 d482665dex101.htm EX-10.1 214608
7 GRAPHIC g482665g0901070817085.jpg GRAPHIC 2030
  Complete submission text file 0001193125-23-227712.txt   452385

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA maia-20230901.xsd EX-101.SCH 2880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230901_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230901_pre.xml EX-101.PRE 11727
9 EXTRACTED XBRL INSTANCE DOCUMENT d482665d8k_htm.xml XML 3445
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 231233149
SIC: 2834 Pharmaceutical Preparations